All Things Newz
Business

FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound -Bloomberg News


Article content

The U.S. Food and Drug Administration has ordered Pfizer Inc to test the effects of an additional course of Paxlovid among people who experience a rebound in COVID-19 after treatment, Bloomberg News reported on Friday.

The company must produce initial results of a randomized controlled trial of a second course of the antiviral by Sept. 30 next year, the report said, citing a letter from the regulator to the company dated Aug. 5. (Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)



Source link

Related posts

ECB policymakers to discuss 50 bp rate hike this week, sources say

Horace Hayward

Ukraine’s creditors agree 2-year freeze on $20 bln overseas debt

Horace Hayward

Olympia Financial Group Inc. Announces September Dividend

Horace Hayward